756 related articles for article (PubMed ID: 19734603)
1. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
Sire JM; Nabeth P; Perrier-Gros-Claude JD; Bahsoun I; Siby T; Macondo EA; Gaye-Diallo A; Guyomard S; Seck A; Breurec S; Garin B
J Infect Dev Ctries; 2007 Dec; 1(3):263-8. PubMed ID: 19734603
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.
Kahlmeter G; Poulsen HO
Int J Antimicrob Agents; 2012 Jan; 39(1):45-51. PubMed ID: 22055529
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
4. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
Smith SP; Manges AR; Riley LW
Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
Borsari AG; Bucher B; Brazzola P; Simonetti GD; Dolina M; Bianchetti MG
Clin Ther; 2008 Nov; 30(11):2090-5. PubMed ID: 19108796
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
[TBL] [Abstract][Full Text] [Related]
7. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey.
Kurutepe S; Surucuoglu S; Sezgin C; Gazi H; Gulay M; Ozbakkaloglu B
Jpn J Infect Dis; 2005 Jun; 58(3):159-61. PubMed ID: 15973007
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey.
Yilmaz N; Agus N; Yurtsever SG; Pullukcu H; Gulay Z; Coskuner A; Kose S; Aydemir S; Gulenc N; Ozgenc O
Med Sci Monit; 2009 Nov; 15(11):PI61-5. PubMed ID: 19865064
[TBL] [Abstract][Full Text] [Related]
9. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
[TBL] [Abstract][Full Text] [Related]
10. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection.
Kahlmeter G; Menday P; Cars O
J Antimicrob Chemother; 2003 Dec; 52(6):1005-10. PubMed ID: 14613955
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
[TBL] [Abstract][Full Text] [Related]
12. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.
Gobernado M; Valdés L; Alós JI; Garcia-Rey C; Dal-Ré R; García-de-Lomas J;
Rev Esp Quimioter; 2007 Jun; 20(2):206-10. PubMed ID: 17893757
[TBL] [Abstract][Full Text] [Related]
13. [E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Talon D; Lallemand-De-Conto S; Thouverez M; Bertrand X
Pathol Biol (Paris); 2004 Mar; 52(2):76-81. PubMed ID: 15001235
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal.
Dromigny JA; Nabeth P; Juergens-Behr A; Perrier-Gros-Claude JD
J Antimicrob Chemother; 2005 Jul; 56(1):236-9. PubMed ID: 15890716
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance of urinary tract pathogens in children in Crete, Greece.
Anatoliotaki M; Galanakis E; Schinaki A; Stefanaki S; Mavrokosta M; Tsilimigaki A
Scand J Infect Dis; 2007; 39(8):671-5. PubMed ID: 17654342
[TBL] [Abstract][Full Text] [Related]
16. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
[TBL] [Abstract][Full Text] [Related]
17. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T
Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data.
Alós JI; Serrano MG; Gómez-Garcés JL; Perianes J
Clin Microbiol Infect; 2005 Mar; 11(3):199-203. PubMed ID: 15715717
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2.
Stratchounski LS; Rafalski VV
Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S4-9. PubMed ID: 16829055
[TBL] [Abstract][Full Text] [Related]
20. [Antimicrobial resistance profiles of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a training hospital in Istanbul].
Ozyurt M; Haznedaroğlu T; Sahiner F; Oncül O; Ceylan S; Ardiç N; Erdemoğlu A
Mikrobiyol Bul; 2008 Apr; 42(2):231-43. PubMed ID: 18697421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
